Cannara Biotech Inc. (LOVE.V)
| Previous Close | 0.8500 |
| Open | 0.8400 |
| Bid | 0.8300 x N/A |
| Ask | 0.8500 x N/A |
| Day's Range | 0.8400 - 0.8400 |
| 52 Week Range | 0.7500 - 1.1500 |
| Volume | |
| Avg. Volume | 21,763 |
| Market Cap | 75.616M |
| Beta (5Y Monthly) | 1.14 |
| PE Ratio (TTM) | 8.40 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- News Direct
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans
Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company's success in the cannabis industry.
- CNW Group
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion
Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced its fiscal first quarter 2024 financial and operating results for the three month period ended November 30, 2023.
- CNW Group
Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")
Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced it has retained Independent Trading Group ("ITG") to provide market making services in accordance with TSX Venture Exchange policies.
